INTENSITY THERAPEUTICS, INC.: current accounts payable
Current accounts payable for INTENSITY THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All INTENSITY THERAPEUTICS, INC. financial histories
What this measure means
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
Exact concept: us-gaap:AccountsPayableCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 583,000 | USD | 2026-03-27 | 10-K · 0001567264-26-000024 |
| At date | 2024-12-31 | 1,219,000 | USD | 2026-03-27 | 10-K · 0001567264-26-000024 |
| At date | 2023-12-31 | 3,048,000 | USD | 2025-03-13 | 10-K · 0001567264-25-000010 |
| At date | 2022-12-31 | 603,000 | USD | 2024-03-14 | 10-K · 0001628280-24-011207 |
Related financial histories
- INTENSITY THERAPEUTICS, INC.: total assets
- INTENSITY THERAPEUTICS, INC.: total liabilities
- INTENSITY THERAPEUTICS, INC.: stockholders equity
- INTENSITY THERAPEUTICS, INC.: cash and cash equivalents
- INTENSITY THERAPEUTICS, INC.: net income or loss
- INTENSITY THERAPEUTICS, INC.: operating cash flow
- INTENSITY THERAPEUTICS, INC.: financing cash flow
- INTENSITY THERAPEUTICS, INC.: investing cash flow
- INTENSITY THERAPEUTICS, INC.: retained earnings or deficit
- INTENSITY THERAPEUTICS, INC.: basic weighted-average shares
- INTENSITY THERAPEUTICS, INC.: diluted weighted-average shares
- INTENSITY THERAPEUTICS, INC.: basic earnings per share
- INTENSITY THERAPEUTICS, INC.: diluted earnings per share
- INTENSITY THERAPEUTICS, INC.: share-based compensation expense
- INTENSITY THERAPEUTICS, INC.: operating income or loss
- INTENSITY THERAPEUTICS, INC.: current assets
- INTENSITY THERAPEUTICS, INC.: current liabilities
- INTENSITY THERAPEUTICS, INC.: operating expenses
- INTENSITY THERAPEUTICS, INC.: research and development expense
- INTENSITY THERAPEUTICS, INC.: common shares outstanding
- INTENSITY THERAPEUTICS, INC.: cash including restricted cash
- INTENSITY THERAPEUTICS, INC.: additional paid-in capital
- INTENSITY THERAPEUTICS, INC.: operating lease right-of-use asset
- INTENSITY THERAPEUTICS, INC.: operating lease liability
- INTENSITY THERAPEUTICS, INC.: other noncurrent assets
- INTENSITY THERAPEUTICS, INC.: other noncurrent liabilities
- INTENSITY THERAPEUTICS, INC.: accrued current liabilities
- INTENSITY THERAPEUTICS, INC.: prepaid expenses and other current assets
- INTENSITY THERAPEUTICS, INC.: net deferred tax assets
- INTENSITY THERAPEUTICS, INC.: general and administrative expense
- INTENSITY THERAPEUTICS, INC.: operating lease payments
Inspect the source
- Entity
- INTENSITY THERAPEUTICS, INC. / CIK 0001567264
- Captured
- 2026-09-20T09:20:42.535Z
- SEC response SHA-256
e3b01a08de9d2eb598fc1afc98358f96588cb7c0f58146200ed65e229957262a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001567264.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))